Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Causes of Rheumatoid Arthritis Genetic and Environmental Factors

Written By

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by
Dr.
Ayesha Bryant
MSPH, MD

Rheumatoid arthritis is a complex disease influenced by both the genes we inherit and the environments we live in. It's not just a matter of bad luck or poor health; it's the result of a delicate interplay between the body’s genetic blueprint and the world around us. Some people may carry the genetic predisposition for RA but never develop the disease. In contrast, others may find that certain environmental triggers, like an infection or smoking, ignite the autoimmune response that leads to RA. 

In this article, we'll explore the genetic and environmental factors that contribute to RA. We'll explore the science behind what makes someone more susceptible to this condition and how various lifestyle and environmental influences can tip the balance toward the onset of RA. 

[signup]

Understanding Rheumatoid Arthritis

Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints. It is characterized by inflammation, pain, and swelling, which can lead to joint damage and loss of function over time. 

Unlike other forms of arthritis, RA tends to affect joints symmetrically, meaning that if one knee or hand is affected, the other is likely to be affected as well. RA can also have systemic effects, impacting other organs such as the skin, heart, lungs, and eyes.

RA develops when the immune system mistakenly attacks the synovium, the lining of the membranes that surround the joints. This autoimmune process leads to inflammation and thickening of the synovium, eventually damaging the cartilage and bone within the joint. 

The exact trigger for this immune response is unknown, but it involves genetic and environmental factors. Overactive immune cells, particularly T and B cells, play a significant role in producing antibodies that attack the body's tissues.

Genetic Factors Contributing to Rheumatoid Arthritis

Genetic predisposition plays a significant role in increasing the risk of developing rheumatoid arthritis (RA). It is estimated that genetic factors account for about 50% of the risk associated with RA. The heritability of RA is approximately 60%, indicating a substantial genetic component in its pathogenesis. This genetic influence is primarily mediated through specific genes that affect the immune system's function, leading to the autoimmune response characteristic of RA.  

Specific Genes Linked to RA

Specific genes linked to RA include the HLA-DRB1 gene and the PTPN22 gene. 

HLA-DRB1 Gene

The HLA-DRB1 gene is one of the most significant genetic markers associated with RA. 

Variations in this gene, particularly the presence of certain alleles known as shared epitopes (SE), are strongly linked to an increased risk of developing RA. These alleles are part of the human leukocyte antigen (HLA) system, which helps the immune system distinguish between self and non-self proteins. 

The presence of specific HLA-DRB1 alleles, such as HLA-DRB104 and HLA-DRB101, is associated with a higher likelihood of developing autoantibody-positive RA.

PTPN22 Gene

The PTPN22 gene is another important genetic factor linked to RA. This gene encodes a protein involved in regulating immune system responses. Variations in the PTPN22 gene have been associated with an increased risk of RA, as they may lead to dysregulation of immune cell signaling, contributing to the autoimmune process. The PTPN22 gene is also implicated in other autoimmune diseases, highlighting its role in immune system regulation.

Other Genetic Markers

In addition to HLA-DRB1 and PTPN22, several other genes and genetic markers have been associated with increased RA risk. These include TRAF1, IL23R, CTLA4, IRF5, STAT4, and CCR6. Specific genes linked to RA include the HLA-DRB1 gene and the PTPN22 gene. 

The HLA-DRB1 gene is one of the most significant genetic markers associated with RA. The PTPN22 gene is also implicated in other autoimmune diseases, highlighting its role in immune system regulation.

Family History and RA Risk

Having a family member with RA can significantly increase one's risk of developing the condition. First-degree relatives of individuals with RA are about three times more likely to develop the disease compared to those without a family history.  

This increased risk highlights the importance of genetic factors in RA. Genetic counseling can be beneficial for individuals with a family history of RA, as it can provide insights into their risk and inform potential preventive measures or early interventions.

Environmental Factors Contributing to Rheumatoid Arthritis

Environmental factors are important in the development and progression of rheumatoid arthritis (RA), often interacting with genetic predispositions to trigger the onset of the disease. Understanding these factors is essential for identifying potential preventive measures and improving management strategies for those at risk. 

1. Infections and Microbial Triggers

Certain infections may act as triggers for rheumatoid arthritis (RA) in individuals who are genetically predisposed. The Epstein-Barr Virus (EBV) has been identified as a potential risk factor, as it can stimulate an immune response that may lead to the development of RA. 

EBV is known to persist in the body after infection, and its presence has been linked to an increased risk of autoimmune conditions, including RA. Other infectious agents, such as certain bacteria and viruses, have also been explored for their potential role in RA onset, although definitive links are yet to be established.

2. Smoking and Rheumatoid Arthritis

Smoking is one of the most significant environmental risk factors for RA. It has been shown to increase the risk of developing seropositive RA, particularly in individuals who carry specific genetic markers like the HLA-DRB1 shared epitope. 

Smoking can worsen the immune response, leading to increased production of autoantibodies and promoting inflammation, which are key processes in RA pathogenesis. Smoking has also been associated with more severe disease progression and a poorer response to treatment.

3. Hormonal Factors

Hormonal changes significantly influence the risk of developing RA, especially in women. Conditions such as early menopause, the use of hormone replacement therapy (HRT), and reproductive history (e.g., having multiple children) have been associated with an increased risk of RA. Pregnancy and menopause can alter hormone levels, which may impact immune system function and potentially trigger or exacerbate RA.

4. Occupational and Environmental Exposures

Exposure to certain occupational and environmental toxins, such as silica dust and asbestos, has been linked to an increased risk of RA. These substances can provoke immune responses that may contribute to the development of autoimmune diseases like RA. 

Additionally, exposure to industrial chemicals and pollutants has been associated with RA risk, highlighting the importance of understanding and mitigating these environmental exposures.

5. Diet and Lifestyle Factors

Diet and lifestyle choices can also influence the development of RA. Obesity is a known risk factor, as excess body weight can lead to increased inflammation. Conversely, diets rich in anti-inflammatory foods, such as the Mediterranean diet, may help reduce the risk of RA. 

Regular physical activity is also beneficial, as it can help maintain joint function and reduce inflammation. While the exact mechanisms are not fully understood, these factors collectively suggest that lifestyle modifications can play a role in managing RA risk.

The Interplay Between Genetics and Environment

Rheumatoid arthritis is a complex disease resulting from the interplay between genetic predisposition and environmental factors. Individuals with certain genetic markers, such as the HLA-DRB1 shared epitope, are more susceptible to developing RA when exposed to specific environmental triggers. 

Epigenetics refers to changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes can be influenced by environmental factors, such as diet, smoking, and exposure to toxins, and they play a significant role in the development of RA. 

Epigenetic mechanisms, including DNA methylation and histone modifications, can regulate immune responses and inflammation, contributing to the pathogenesis of RA.

Studies have identified specific epigenetic changes associated with RA, suggesting that these modifications could serve as biomarkers for the disease. 

For instance, differential DNA methylation patterns have been observed in immune cells of individuals with RA, indicating that environmental influences can lead to epigenetic changes that promote disease development

[signup]

Key Takeaways

  • Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects joints and can also impact other organs due to the immune system mistakenly attacking the body's tissues.
  • Genetic factors, such as variations in the HLA-DRB1 and PTPN22 genes, significantly increase the risk of developing RA, with heritability estimated at around 60%.
  • Environmental factors like smoking, infections (e.g., Epstein-Barr Virus), and exposure to toxins interact with genetic predispositions, further increasing the risk of RA.
  • Hormonal changes, diet, and lifestyle choices, including obesity and physical activity, also influence the likelihood of developing RA, with some factors potentially serving as preventive measures.
  • The interplay between genetics and environmental triggers, including epigenetic changes, highlights the complexity of RA development, emphasizing the importance of early detection and lifestyle modifications for those at risk.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024, March 19). Unveiling the Shadow: How Smoking Casts a Long-Term Impact on Immune Health. Rupa Health. https://www.rupahealth.com/post/unveiling-the-shadow-how-smoking-casts-a-long-term-impact-on-immune-health

Al, N. M., Simpson, B., & Jialal, I. (2019, April 5). Genetics, Epigenetic Mechanism. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532999/

Alpízar-Rodríguez, D., Pluchino, N., Canny, G., Gabay, C., & Finckh, A. (2016). The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology, 56(8), kew318. https://doi.org/10.1093/rheumatology/kew318

Armitage, L. H., Wallet, M. A., & Mathews, C. E. (2021). Influence of PTPN22 Allotypes on Innate and Adaptive Immune Function in Health and Disease. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.636618

Chang, K., Yang, S., Kim, S., Han, K., Park, S., & Shin, J. (2014). Smoking and Rheumatoid Arthritis. International Journal of Molecular Sciences, 15(12), 22279–22295. https://doi.org/10.3390/ijms151222279

Cooney, J. K., Law, R.-J., Matschke, V., Lemmey, A. B., Moore, J. P., Ahmad, Y., Jones, J. G., Maddison, P., & Thom, J. M. (2011). Benefits of Exercise in Rheumatoid Arthritis. Journal of Aging Research, 2011(1), 1–14. https://doi.org/10.4061/2011/681640

Creedon, K. (2022, May 26). How To Naturally Relieve Rheumatoid Arthritis Pain. Rupa Health. https://www.rupahealth.com/post/natural-treatments-for-rheumatoid-arthritis-pain

de, G., Batista, L., Santos, Menta, C., & Margarete Dulce Bagatini. (2024). The impacts of obesity in rheumatoid arthritis and insights into therapeutic purinergic modulation. International Immunopharmacology, 136, 112357–112357. https://doi.org/10.1016/j.intimp.2024.112357

Dedmon, L. E. (2020). The genetics of rheumatoid arthritis. Rheumatology, 59(10). https://doi.org/10.1093/rheumatology/keaa232

Desai, M. K., & Brinton, R. D. (2019). Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Frontiers in Endocrinology, 10(265). https://doi.org/10.3389/fendo.2019.00265

Falahee, M., & Raza, K. (2022). Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini Review. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.883287

Ilar, A., Klareskog, L., Saevarsdottir, S., Wiebert, P., Askling, J., Gustavsson, P., & Alfredsson, L. (2019). Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study. RMD Open, 5(2), e000978. https://doi.org/10.1136/rmdopen-2019-000978

Jiang, L.-Q., Zhang, R.-D., Musonye, H. A., Zhao, H.-Y., He, Y.-S., Zhao, C.-N., He, T., Tian, T., Gao, Z.-X., Fang, Y., Wang, P., Ni, J., & Pan, H.-F. (2024). Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants. RMD Open, 10(1), e003338. https://doi.org/10.1136/rmdopen-2023-003338

Jiang, X., & Alfredsson, L. (2020). Modifiable environmental exposure and risk of rheumatoid arthritis—current evidence from genetic studies. Arthritis Research & Therapy, 22(1). https://doi.org/10.1186/s13075-020-02253-5

Jin, B., Li, Y., & Robertson, K. D. (2011). DNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy? Genes & Cancer, 2(6), 607–617. https://doi.org/10.1177/1947601910393957

Kronzer, V. L., Crowson, C. S., Sparks, J. A., Myasoedova, E., & Davis, J. (2021). Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis. Arthritis Care & Research, 73(2), 180–187. https://doi.org/10.1002/acr.24115

Kurkó, J., Besenyei, T., Laki, J., Glant, T. T., Mikecz, K., & Szekanecz, Z. (2013). Genetics of Rheumatoid Arthritis — A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 45(2), 170–179. https://doi.org/10.1007/s12016-012-8346-7

Mehri, F., Jenabi, E., Bashirian, S., Shahna, F. G., & Khazaei, S. (2020). The association Between Occupational Exposure to silica and Risk of Developing Rheumatoid Arthritis: A Meta-Analysis. Safety and Health at Work, 11(2), 136–142. https://doi.org/10.1016/j.shaw.2020.02.001

Nemtsova, M. V., Zaletaev, D. V., Bure, I. V., Mikhaylenko, D. S., Kuznetsova, E. B., Alekseeva, E. A., Beloukhova, M. I., Deviatkin, A. A., Lukashev, A. N., & Zamyatnin, A. A. (2019). Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis. Frontiers in Genetics, 10(570). https://doi.org/10.3389/fgene.2019.00570

Padyukov, L. (2022). Genetics of rheumatoid arthritis. Seminars in Immunopathology, 44(1), 47–62. https://doi.org/10.1007/s00281-022-00912-0

Paraskevi Vranou, Athanasios Gkoutzourelas, Athanatou, D., Efterpi Zafiriou, Grammatikopoulou, M. G., & Bogdanos, D. P. (2020). Let Food Be Thy Medicine: The Case of The Mediterranean Diet in Rheumatoid Arthritis. Mediterranean Journal of Rheumatology, 31(3), 325–329. http://www.mjrheum.org/sept-2020/newsid792/259/showfulltext792/1

Qiu, F. (2016). Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget, 8(1). https://doi.org/10.18632/oncotarget.13613

Scherer, H. U., Häupl, T., & Burmester, G. R. (2020). The Etiology of Rheumatoid Arthritis. Journal of Autoimmunity, 110(110), 102400. https://doi.org/10.1016/j.jaut.2019.102400

Weinberg, J. (2023, July 27). Integrative Approaches to the Testing and Treatment of Rheumatoid Arthritis: A Comprehensive Review. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-testing-and-treatment-of-rheumatoid-arthritis-a-comprehensive-review

Yap, H.-Y., Tee, S., Wong, M., Chow, S.-K., Peh, S.-C., & Teow, S.-Y. (2018). Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development. Cells, 7(10), 161. https://doi.org/10.3390/cells7100161

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source